MA47687B1 - Vecteurs de virus adéno-associé de clade f, et leurs utilisations - Google Patents

Vecteurs de virus adéno-associé de clade f, et leurs utilisations

Info

Publication number
MA47687B1
MA47687B1 MA47687A MA47687A MA47687B1 MA 47687 B1 MA47687 B1 MA 47687B1 MA 47687 A MA47687 A MA 47687A MA 47687 A MA47687 A MA 47687A MA 47687 B1 MA47687 B1 MA 47687B1
Authority
MA
Morocco
Prior art keywords
raav
relates
associated virus
aavhu68
adeno
Prior art date
Application number
MA47687A
Other languages
English (en)
Other versions
MA47687A (fr
Inventor
James Wilson
Qiang Wang
April Giles
Kevin Turner
Original Assignee
Univ Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania
Priority claimed from PCT/US2018/019992 external-priority patent/WO2018160582A1/fr
Publication of MA47687A publication Critical patent/MA47687A/fr
Publication of MA47687B1 publication Critical patent/MA47687B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A61K35/761—Adenovirus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne un vecteur de virus adéno-associé recombinant (raav) comprenant une capside aavhu68 produite dans un système de production comprenant une séquence nucléotidique seq id no: 1, ou une séquence au moins identique à 75 % à celle-ci qui code pour la seq id no: 2. La capside aavhu68 comprend des sous-populations de résidus asparagine hautement désamidés dans des paires asparagine-glycine dans la séquence d'acides aminés seq id no: 2. L'invention concerne également des compositions comprenant le raav et des utilisations de celles-ci. De plus, l'invention concerne un raav ayant une capside aav modifiée comprenant au moins une sous-population de protéines vpl ou vp2 ayant une val à la position de l'acide aminé 157 par rapport à la numérotation de l'aavhu68 vpl.
MA47687A 2017-02-28 2018-02-27 Vecteurs de virus adéno-associé de clade f, et leurs utilisations MA47687B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762464748P 2017-02-28 2017-02-28
PCT/US2018/019992 WO2018160582A1 (fr) 2017-02-28 2018-02-27 Vecteur de clade f de virus adéno-associé (aav) et ses utilisations

Publications (2)

Publication Number Publication Date
MA47687A MA47687A (fr) 2021-03-31
MA47687B1 true MA47687B1 (fr) 2024-03-29

Family

ID=91034127

Family Applications (1)

Application Number Title Priority Date Filing Date
MA47687A MA47687B1 (fr) 2017-02-28 2018-02-27 Vecteurs de virus adéno-associé de clade f, et leurs utilisations

Country Status (1)

Country Link
MA (1) MA47687B1 (fr)

Also Published As

Publication number Publication date
MA47687A (fr) 2021-03-31

Similar Documents

Publication Publication Date Title
MX2019010275A (es) Novedoso vector del subtipo f del virus adenoasociado (aav) y usos de este.
UA124343C2 (uk) Капсиди аденоасоційованого вірусу і спосіб його використання
EA202091712A1 (ru) МОДИФИЦИРОВАННЫЙ КАПСИДНЫЙ БЕЛОК rAAV ДЛЯ ГЕННОЙ ТЕРАПИИ
WO2022076750A3 (fr) Virus adéno-associés recombinants pour administration musculaire ou dans le snc
NO20081654L (no) Stabiliserte GLP-1-analoger
MA56142B1 (fr) Protéine modifiée séparée vp1 de capside de aav5
BR112021020957A2 (pt) Capsídeos de vírus adenoassociado (aav) variante para liberação intravítrea
MX2023012722A (es) Capsides de aav y usos de las mismas.
WO2021226267A3 (fr) Compositions de virus adéno-associés compatibles entre espèces et leurs méthodes d'utilisation
MX2022002961A (es) Metodos para tratar enfermedades neovasculares oculares usando variantes de aav2 que codifican para aflibercept.
ATE453663T1 (de) Zusammensetzungen von für pathogene stämme spezifischen polypeptiden und deren verwendung als impfstoffe und in der immuntherapie
MX2022000551A (es) Proteínas de la cápside de aav modificadas para el tratamiento de una enfermedad artrítica.
WO2021239838A3 (fr) Polypeptides du coronavirus 2 associé au syndrome respiratoire aigu sévère (sars-cov-2) et leurs utilisations à des fins vaccinales
MA47687B1 (fr) Vecteurs de virus adéno-associé de clade f, et leurs utilisations
FR3072686B1 (fr) Systeme d'expression baculovirus
MA56910B1 (fr) Gène cca pour la résistance aux virus
PH12018500468A1 (en) Fusion protein
CA2072350A1 (fr) Polypeptides impliques dans l'expression de la resistance aux antibiotiques glycopeptidiques
MX2023003807A (es) Virus adenoasociados recombinantes para administracion en el snc o el musculo.
EA201992023A1 (ru) Вектор на основе аденоассоциированного вируса (aav) клады f и его применения
BR112022003206A2 (pt) Métodos para tratar doenças neovasculares oculares usando variantes de aav2 que codificam aflibercepte
MA64618A1 (fr) Protéine modifiée séparée vp1 de capside aav9
PE20241345A1 (es) Proteina vp1 modificada y aislada de la capside del virus adenoasociado del serotipo 5 (aav5), capside y vector basados en esta
WO2023060272A3 (fr) Virus adéno-associés recombinants pour administration tropique au snc
WO2021081515A3 (fr) Compositions et procédés pour le traitement du virus de l'immunodéficience humaine